Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RARE

Ultragenyx Pharmaceutical Inc

May 29 • 04:00PM ET

23.94

+0.68 2.92 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM KRYS MIRM PTCT IONS ALNY INCY VRTX KOD

| Held by: XBI VTI VB VBK VXF IBB IWP SCHA IWF IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.11	Insider Own	8.98%	Shs Outstand	98.00M	Perf Week	0.97%
Market Cap	2.36B	Forward P/E	-	EPS next Y	-0.70	Insider Trans	-1.52%	Shs Float	89.65M	Perf Month	-0.99%
Enterprise Value	3.14B	PEG	-	EPS next Q	-1.22	Inst Own	97.96%	Short Float	15.59%	Perf Quarter	2.35%
Income	-609.36M	P/S	3.52	EPS this Y	23.11%	Inst Trans	4.82%	Short Ratio	7.46	Perf Half Y	-28.59%
Sales	669.43M	P/B	-	EPS next Y	84.40%	ROA	-46.73%	Short Interest	13.98M	Perf YTD	4.09%
Book/sh	-2.41	P/C	5.60	EPS next 5Y	-	ROE	-656.54%	52W High	42.37 -43.50%	Perf Year	-31.66%
Cash/sh	4.27	P/FCF	-	EPS past 3/5Y	16.78% -13.72%	ROIC	-68.31%	52W Low	18.29 30.89%	Perf 3Y	-51.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.81% 19.95%	Gross Margin	78.49%	Volatility	3.55% 4.47%	Perf 5Y	-76.46%
Dividend TTM	-	EV/Sales	4.70	EPS Y/Y TTM	-3.82%	Oper. Margin	-83.92%	ATR (14)	1.06	Perf 10Y	-65.09%
Dividend Ex-Date	-	Quick Ratio	1.85	Sales Y/Y TTM	13.33%	Profit Margin	-91.03%	RSI (14)	48.48	Recom	1.32
Dividend Gr. 3/5Y	- -	Current Ratio	2.02	EPS Q/Q	-17.21%	SMA20	-3.08%	Beta	0.37	Target Price	52.05
Payout	-	Debt/Eq	-	Sales Q/Q	-2.36%	SMA50	1.87%	Rel Volume	0.98	Prev Close	23.26
Employees	1371	LT Debt/Eq	-	Earnings	May 05 AMC	SMA200	-12.79%	Avg Volume	1.87M	Price	23.94
IPO	Jan 31, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.67% -14.03%	Trades		Volume	1,840,302	Change	2.92%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)